Inflammatory Myofibroblastic Tumor — Trials

Inflammatory Myofibroblastic Tumor — Trials · CancerIndex

Clinical trials

Registered studies

7 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02465528	Ceritinib Rare Indications Study in ALK+ Tumors	terminated	Phase 2	22	Novartis PharmaceuticalsINDUSTRY	8	Dec 27, 2019	clinicaltrials

Data updated 22 days agoSource updated Dec 27, 2019source: clinicaltrials